| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |